Menu

 

Letter

Prevention of diabetes: Lifestyle and metformin are the way forward

BMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.333.7574.918-d (Published 26 October 2006)
Cite this as: BMJ 2006;333:918.5

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John S Ashcroft, general practitioner (john.ashcroft@nhs.net)
  1. Old Station Surgery, Ilkeston, Derbyshire DE7 8ES

    EDITOR—The concern expressed by Heneghan et al1 that drug treatment to prevent diabetes may not be as attractive as it first seems, may be justified for rosiglitazone but is not for metformin, which is effective, safe, and cheap.

    While the 31% reduction in new cases of diabetes with metformin in the Diabetes Prevention Program (DPP)2 seems unimpressive compared with the lifestyle groups' 58%, in …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Latest comments and most commented

    THIS WEEK'S POLL

    Read related article

    See previous polls